Item 8.01 Other Events.


Press Release

On April 11, 2022, Recursion Pharmaceuticals, Inc. issued a press release announcing the U.S. Food and Drug Administration (FDA) has granted the company Fast Track designation for REC-4881 for the potential treatment of Familial Adenomatous Polyposis in patients who have previously undergone a colectomy/proctocolectomy. A copy of the press release is attached hereto as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits

Exhibit
  No.       Description

99.1          Press Release issued by Recursion Pharmaceuticals, Inc., dated
            April 11, 2022

104         Cover Page Interactive Data File (embedded within the Inline XBRL
            document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses